NIH Scientists Develop Blood Test to Help Improve Liver Cancer Screening
A specific viral exposure signature that could accurately distinguish people with HCC from those with chronic liver disease and healthy volunteers.
Read More
Search Results for: prostate cancer
FDA Approves BRACAnalysis CDx as a Companion Diagnostic for HRR-Mutated Prostate Cancer
BRACAnalysis CDx is the only FDA-approved germline test to identify men with BRCA1 and BRCA2 mutations, a subpopulation of HRR gene mutations.
Read More
Study Verifies Analytical Performance of Proclarix Prostate Cancer Diagnostic
The report highlights the analytical performance of two CE-marked assays that measure the prostate cancer-related protein biomarkers THBS1 and CTSD in blood.
Read More
Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Read MoreBiocare Medical Launches Seven Antibody Markers for Clinical Diagnostic and Cancer Research Applications
The launch focuses on several immunooncology markers that are critical for early-stage cancer drug development and patient treatment.
Read More